Otolaryngologist Performance in the Merit-Based Incentive Payment System in 2017.


Journal

JAMA otolaryngology-- head & neck surgery
ISSN: 2168-619X
Titre abrégé: JAMA Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 101589542

Informations de publication

Date de publication:
01 07 2020
Historique:
pubmed: 22 5 2020
medline: 3 3 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

The Merit-Based Incentive Payment System (MIPS) for Medicare is the largest pay-for-performance program in the history of health care. Although the Centers for Medicare & Medicaid Services (CMS) launched the MIPS in 2017, the participation and performance of otolaryngologists in this program remain unclear. To characterize otolaryngologist participation and performance in the MIPS in 2017. Retrospective cross-sectional analysis of otolaryngologist participation and performance in the MIPS from January 1 through December 31, 2017, using the publicly available CMS Physician Compare 2017 eligible clinician public reporting database. The number and proportion of active otolaryngologists who participated in the MIPS in 2017 were determined. Overall 2017 MIPS payment adjustments received by participants were determined and stratified by reporting affiliation (individual, group, or alternative payment model [APM]). Payment adjustments were categorized based on overall MIPS performance scores in accordance with CMS methodology: penalty (<3 points), no payment adjustment (3 points), positive adjustment (between 3 and 70 points), or bonus for exceptional performance (≥70 points). In 2017, CMS required 6512 of 9526 (68.4%) of active otolaryngologists to participate in the MIPS. Among these otolaryngologists, 5840 (89.7%) participated; 672 (10.3%) abstained and thus incurred penalties (-4% payment adjustment). The 6512 participating otolaryngologists reported MIPS data as individuals (1990 [30.6%]), as groups (3033 [46.6%]), and through CMS-designated APMs (964 [14.8%]). The majority (4470 of 5840 [76.5%]) received bonuses (maximum payment adjustment, +1.9%) for exceptional performance, while a minority received only a positive payment adjustment (1006 of 5840 [17.2%]) or did not receive an adjustment (364 of 5840 [6.2%]). Whereas nearly all otolaryngologists reporting data via APMs (936 of 964 [97.1%]) earned bonuses for exceptional performance, fewer than 70% of otolaryngologists reporting data as individuals (1124 of 1990 [56.5%]) or groups (2050 of 3033 [67.6%]) earned such bonuses. Of note, nearly all otolaryngologists incurring penalties (658 of 672 [97.9%]) were affiliated with groups. Most otolaryngologists participating in the 2017 MIPS received performance bonuses, although variation exists within the field. As CMS continues to reform the MIPS and raise performance thresholds, otolaryngologists should consider adopting measures to succeed in the era of value-based care.

Identifiants

pubmed: 32437498
pii: 2766220
doi: 10.1001/jamaoto.2020.0847
pmc: PMC7243162
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

639-646

Références

JAMA Dermatol. 2020 Apr 1;156(4):466-468
pubmed: 32074254
JAMA. 2019 Mar 26;321(12):1157-1158
pubmed: 30830150
Ann Intern Med. 2017 Mar 7;166(5):368-369
pubmed: 28114662
Ann Intern Med. 2017 Jul 18;167(2):122-124
pubmed: 28505630
J Am Coll Radiol. 2020 Apr;17(4):525-533
pubmed: 31669152
Otolaryngol Head Neck Surg. 2018 Sep;159(3):410-413
pubmed: 29734874
JAMA Otolaryngol Head Neck Surg. 2020 Feb 1;146(2):97-98
pubmed: 31830230
N Engl J Med. 2015 May 21;372(21):1977-9
pubmed: 25902381

Auteurs

Roy Xiao (R)

Department of Otolaryngology, Massachusetts Eye and Ear, Boston.
Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.

Vinay K Rathi (VK)

Department of Otolaryngology, Massachusetts Eye and Ear, Boston.
Harvard Business School, Boston, Massachusetts.
Mass General Brigham, Boston, Massachusetts.

Neil Kondamuri (N)

Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Shekhar K Gadkaree (SK)

Department of Otolaryngology, Massachusetts Eye and Ear, Boston.
Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.

Krish Suresh (K)

Department of Otolaryngology, Massachusetts Eye and Ear, Boston.
Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.

Justin C McCarty (JC)

St Elizabeth's Medical Center, Department of Surgery, Tufts University School of Medicine, Boston, Massachusetts.
Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Patient-Reported Outcomes, Value and Experience (PROVE) Center, Brigham and Women's Hospital, Boston, Massachusetts.

Regan W Bergmark (RW)

Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.
Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Patient-Reported Outcomes, Value and Experience (PROVE) Center, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Matthew R Naunheim (MR)

Department of Otolaryngology, Massachusetts Eye and Ear, Boston.
Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.

Mark A Varvares (MA)

Department of Otolaryngology, Massachusetts Eye and Ear, Boston.
Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH